Zymergen (Zymergen) Change In Payables And Accrued Expense : $-18.57 Mil (TTM As of Jun. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Zymergen Change In Payables And Accrued Expense?

Zymergen's Change In Payables And Accrued Expense for the quarter that ended in Jun. 2022 was $1.50 Mil. It means Zymergen's Accounts Payable & Accrued Expense increased by $1.50 Mil from Mar. 2022 to Jun. 2022 .

Zymergen's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2021 was $-23.41 Mil. It means Zymergen's Accounts Payable & Accrued Expense declined by $23.41 Mil from Dec. 2020 to Dec. 2021 .

Zymergen Change In Payables And Accrued Expense Historical Data

The historical data trend for Zymergen's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zymergen Change In Payables And Accrued Expense Chart

Zymergen Annual Data

Trend

Dec19

Dec20

Dec21

Change In Payables And Accrued Expense

1.01

1.12

-23.41

Zymergen Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
Change In Payables And Accrued Expense	Get a 7-Day Free Trial						5.52	-7.70	-14.77	2.41	1.50

Zymergen Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-18.57 Mil.

Zymergen Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Zymergen's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Zymergen (Zymergen) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Zymergen Inc (NAS:ZY) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

5980 Horton Street, Suite 105, Emeryville, CA, USA, 94608

Website

https://www.zymergen.com

Zymergen Inc is a biofacturing company. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials.

Executives

Enakshi Singh	officer: Chief Financial Officer	5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Mina Kim	officer: Chief Legal Officer	C/O ACELYRIN, INC., 4149 LIBERTY CANYON RD., AGOURA HILLS CA 91301
Zachariah Serber	director, officer: Chief Science Officer	5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Aaron Kimball	officer: Chief Technology Officer	5980 HORTON ST., STE 105 EMERYVILLE CA 94025
Jay T Flatley	director	9885 TOWNE CENTRE DR, SAN DIEGO CA 92121
Svf Excaliber (cayman) Ltd	10 percent owner	27 HOSPITAL ROAD, WALKERS CORPORATE LTD., CAYMAN CORPORATE CENTRE, GEORGE TOWN, GRAND CAYMAN E9 KY-9008
Josh Hoffman	director, officer: Chief Executive Officer	5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Erik Jedidiah Dean	officer: VP Operations and Engineering	5980 HORTON ST., STE 105 EMERYVILLE CA 94608
Rohit Sharma	director	575 HIGH STREET PALO ALTO CA 94301
Travis Murdoch	director	1 CIRCLE STAR WAY SAN CARLOS CA 94070
Matthew Ocko	director	270 UNIVERSITY AVENUE, PALO ALTO CA 94301
Svf Endurance (cayman) Ltd	10 percent owner	C/O WALKERS CORPORATE LIMITED, 27 HOSPITAL ROAD, GEORGE TOWN E9 KY1-9008
Softbank Vision Fund (aiv M1) L.p.	10 percent owner	251 LITTLE FALLS DRIVE, WILMINGTON DE 19808
Sb Investment Advisers (uk) Ltd	10 percent owner	69 GROSVENOR STREET, LONDON X0 W1K 3JP
Christine Marie Gorjanc	director	4500 GREAT AMERICA PARKWAY, SANTA CLARA CA 95054